V
$406.57 at the check
LONG

Kairon's answer on V: positive but cautious.

Leaning up, but not enough conviction for a trade.

Checked Oct 21, 2026 at $406.57, time frame 3–6 months; evidence insufficient for a high-conviction long-term allocation, confidence high
Why? For, against, what would change it
  • ForStrong profits, cash generation, and fewer shares support the positive outlook.
  • AgainstThe price looks stretched, while limited potential gains and conflicting signals weaken the case.
  • What would change the pictureA fall below $396.06 and $393.43 could open the way to $374.22.
Result check on Apr 19, 2027: open.

The 10-second check

Loading filings…

Both sides

Read the full debate between the bull and the bear analyst

Bull Analyst: ## BULL CASE ARGUMENTS

### Argument 1 - [Category: Growth] [MEDIUM conviction]
Evidence: Next-year consensus EPS is $15.02, up from $14.87 90 days ago; forecast EPS growth is 13.53%, versus forecast revenue growth of 10.96%. Current-year EPS consensus increased to $13.23 from $13.15. *(Fundamentals Report)*

Thesis: Annual earnings expectations have improved despite near-term estimate cuts, supporting an earnings-led bull case rather than one requiring multiple expansion. However, 13.53% EPS growth is a forecast—not filed growth—and 3 downward versus 1 upward next-year revisions over the last 30 days limit conviction.

### Argument 2 - [Category: Growth] [HIGH conviction]
Evidence: Reported operating margin is 66.13%, net margin is 50.78%, and free cash flow is $20.404 billion. Shares outstanding declined from 2.05 billion to 1.88 billion, a reported 8.5% reduction over three years. *(Fundamentals Report)*

Thesis: The bull case has observable support in profitability, cash generation, and a shrinking share base—not merely projected growth. The 8.5% share-count reduction supports per-share economics, although missing cash-conversion and debt-coverage data prevent a broader high-conviction balance-sheet claim.

### Argument 3 - [Category: Catalyst] [MEDIUM conviction]
Evidence: The last 4 reported quarters delivered positive EPS surprises of 0.28%, 0.88%, 6.79%, and 2.76%. Current-quarter consensus has declined only from $3.450 to $3.442, approximately 0.23%. *(Fundamentals Report; percentage calculated from reported estimates)*

Thesis: The recent execution record challenges a thesis of already-deteriorating earnings delivery: all 4 reports exceeded expectations, while the current-quarter estimate reduction is approximately 0.23%. This supports the possibility of another satisfactory report, but the two smallest beats—0.28% and 0.88%—show that the historical cushion has sometimes been narrow.

### Argument 4 - [Category: Technical] [MEDIUM conviction]
Evidence: Price of $406.57 is above the $374.22 50-day average and $338.92 200-day average; MACD is 9.20, versus a 5.61 signal line. Quant signals include Kalman slope +91, MA trend +83, OBV trend +100, and HMM bull-state probability 0.88; SPY is 6.4% above its 200-day average. *(Technical and Quant Reports)*

Thesis: Multiple trend measures support maintaining a bullish directional bias rather than assuming an immediate trend reversal. However, RSI of 75.60 and Hurst exponent of 0.37 make this evidence stronger for buying a pullback than for chasing the current price.

### Argument 5 - [Category: Valuation] [MEDIUM conviction]
Evidence: Current-price technical reward/risk is only 1.03:1, using the $420 target and $393.43 stop reference. At the reported $396.06 support, those same levels imply approximately 9.1:1 nominal reward/risk; using a wider, illustrative 2× ATR risk allowance of $13.50 instead implies approximately 1.77:1. *(Technical Report; entry-scenario calculations)*

Thesis: The strongest actionable bull case is entry-sensitive: a pullback toward $396.06 improves prospective reward/risk without requiring a higher target than $420. The 9.1:1 figure relies on an unusually tight $2.63 stop distance relative to $6.75 ATR, so the wider-stop 1.77:1 scenario is the more credible planning reference—not a guaranteed execution outcome.

## BEAR COUNTER-ARGUMENTS

*No separate last-bear argument was supplied. The responses below address the explicit bearish points in the reports.*

Bear said: “At 34.60x trailing earnings and 27.06x forward earnings, with only 4.2% mean-target upside, valuation is unattractive.”

Counter: Forecast EPS growth of 13.53%, annual EPS revisions to $15.02 from $14.87, and 4 consecutive beats provide a basis for earnings-supported returns. Nevertheless, 4.2% mean-target upside is insufficient to establish an attractive current-price margin of safety; the bull response is entry discipline near $396.06, not an unsupported claim that the shares are cheap.

Bear said: “Estimate revisions are deteriorating.”

Counter: The current-quarter reduction is approximately 0.23%, while next-year consensus is approximately 1.01% higher than 90 days ago, at $15.02 versus $14.87. The bear is right that 3 downward versus 1 upward recent revisions could signal weakening momentum; the counter-data show mixed revisions, not broad annual estimate deterioration.

Bear said: “Overbought conditions and mean reversion undermine the rally.”

Counter: RSI reversion of −97, stochastic RSI of −100, and Hurst 0.37 are legitimate timing warnings. Against them, MA trend +83 and HMM bull probability 0.88 support an intact bullish backdrop; the appropriate synthesis is to prefer a pullback toward $396.06, rather than dismiss the trend or chase $406.57.

Bear said: “The quant engine does not support a high-conviction long.”

Counter: Correct: its composite is only +18.0/100, with conviction 1.9/10. Still, the 21-day simulation has expected return +1.11%, probability of gain 56.96%, and probability of gaining more than 5% of 26.62%, versus 16.98% probability of losing more than 5%—a modest positive asymmetry, not a strong standalone buy signal. The −9.34% fifth-percentile outcome prevents treating that edge as low-risk.

Bear said: “Liquidity and earnings quality are unresolved.”

Counter: The 0.985x current ratio is below 1.0x, and missing debt-coverage and cash-conversion metrics remain genuine gaps. Reported FCF of $20.404 billion and an 8.5% share-count reduction provide counter-evidence of cash generation and per-share support, but do not establish adequate liquidity or prove the sustainability of capital returns.

Bear said: “Insider positioning provides no endorsement.”

Counter: Radar reports 0 purchases and 2 sales totaling $2.8 million, so there is no insider-buying bull signal. Its aggregate strength is 0/100, however, and the supplied data contain no holdings or transaction-purpose context; these sales temper conviction but cannot independently establish fundamental deterioration.

## BULL THESIS INVALIDATION LEVEL

The tactical bull thesis breaks if V closes below $374.22, the reported 50-day moving average, indicating failure of the intermediate trend underpinning the entry thesis. A close below $393.43 is an earlier momentum warning and invalidates a tight-stop tactical setup.

The earnings-led thesis requires reassessment if next-year EPS consensus falls below $14.87, reversing the reported 90-day improvement to $15.02. That would remove a central bullish support while the reported forward valuation remains 27.06x.

## OVERALL BULL CONVICTION: MEDIUM (6/10)

Justify: There is 1 HIGH-conviction argument, grounded in reported 66.13% operating margin, $20.404 billion FCF, and 8.5% share-count reduction. Forecast EPS growth of 13.53% and HMM bull probability of 0.88 support the direction, but 4.2% mean-target upside, quant conviction of 1.9/10, and missing earnings-quality metrics rule out a high-conviction current-price recommendation.

Committee position: Favor an earnings-backed, pullback-entry long near $396.06 over a full-size momentum purchase at $406.57.
Bear Analyst: ## BEAR CASE RISKS

### Risk 1 - [Category: Valuation/Fundamental] [MEDIUM conviction]
Evidence: V trades at 34.60x trailing P/E and 27.06x forward P/E, while the analyst mean target of $423.80 implies only 4.2% upside from approximately $406.60. Peer valuation data are unavailable, so there is no evidence that V is inexpensive relative to comparable companies.

Risk: The bullish thesis requires earnings to grow into an already demanding valuation. A multiple contraction can overwhelm the forecast 13.53% EPS growth, particularly because the consensus target offers only 4.2% upside and target dispersion is 34.2%, with estimates ranging from $330 to $475.

Quantified downside: If forward P/E contracts from 27.06x to 22.0x while EPS remains at $15.02, the implied price falls from approximately $406.60 to $330.44, or 18.7% downside. A decline to 20.0x would imply approximately 26.1% downside.

---

### Risk 2 - [Category: Technical/Mean Reversion] [HIGH conviction]
Evidence: RSI is 75.60, price is approximately 19.9% above the 200-day SMA, and V is trading near the upper Bollinger Band at $406.57 versus $411.30. The quant engine reports strongly negative reversal signals: RSI reversion −97, stochastic RSI −100, Bollinger position −86, Williams %R −92, and Hurst exponent 0.37, indicating a mean-reverting rather than persistent-trending process.

Risk: The bull case relies heavily on continuation signals—Kalman slope +91, MA trend +83, and HMM bull probability 0.88—but the engine explicitly indicates that mean-reversion signals are more reliable in the current regime. The rally could therefore remain fundamentally intact while still producing a sharp tactical drawdown.

Quantified downside: A retreat to the $374.22 50-day SMA would represent approximately 7.9% downside from $406.57. A deeper reversion to the $338.92 200-day SMA would represent approximately 16.6% downside. The Monte Carlo model independently places the 21-trading-day fifth percentile at −9.34%.

---

### Risk 3 - [Category: Fundamental/Catalyst] [MEDIUM conviction]
Evidence: Next-year EPS consensus rose only from $14.87 to $15.02, an increase of approximately 1.0% over 90 days, while the most recent 30-day revision breadth was 1 upward versus 3 downward. Current-quarter EPS declined from $3.450 to $3.442, or approximately 0.23%.

Risk: The bullish growth argument depends on a forecast of 13.53% EPS growth, not filed historical growth. The recent revision breadth is negative despite the modest 90-day annual improvement, suggesting that forward estimates may be losing momentum. The four prior beats do not eliminate this risk: two of the beats were only 0.28% and 0.88%.

Quantified downside: If next-year EPS reverts from $15.02 to $14.87 and the forward multiple contracts from 27.06x to 24.0x, implied value would decline from approximately $406.60 to $356.88, or 12.2% downside. A 10% EPS shortfall to approximately $13.52, at 24.0x, would imply approximately 20.2% downside.

---

### Risk 4 - [Category: Fundamental/Balance Sheet] [MEDIUM conviction]
Evidence: The reported current ratio is 0.985x, below the conventional 1.0x coverage threshold. Cash conversion, accruals, net debt/EBITDA, and interest coverage are all N/A, meaning the reported $20.404 billion FCF cannot be independently assessed against net income, debt obligations, or working-capital needs.

Risk: The bull argument treats high margins and reported FCF as evidence of robust financial quality, but the unavailable OCF/net-income and debt-coverage data prevent that conclusion. A current ratio below 1.0x is not proof of distress, but it leaves less balance-sheet cushion if receivables, settlement liabilities, or operating cash flow weaken.

Quantified downside: If a balance-sheet or earnings-quality issue produced a 10% EPS haircut and valuation simultaneously compressed from 27.06x to 24.0x, the implied price would be approximately $365.40, or 10.1% below the current price. A 15% EPS haircut under the same multiple would imply approximately $345.10, or 15.1% downside.

---

### Risk 5 - [Category: Positioning/Catalyst] [LOW conviction]
Evidence: Kairon Radar records 0 insider purchases, 2 insider sellers, and $2.8 million of disclosed sales over the last 90 days. Radar signal strength is only 0/100, so this is not a dominant signal, but it provides no insider-buying confirmation at a valuation of 27.06x forward earnings.

Risk: Insider selling alone does not establish deterioration because transaction-purpose and ownership-context data are unavailable. However, the absence of any reported purchases means insiders are not providing a positive confirmation signal while the stock is near an overbought level of RSI 75.60.

Quantified downside: If the absence of insider buying coincides with a modest sentiment reversal and price falls to the first technical support at $396.06, the immediate downside is approximately 2.6%. If selling pressure drives a normal two-ATR correction, using ATR of $6.75, the downside is approximately 6.6% to $393.07.

---

## BULL COUNTER-ARGUMENTS

Bull said: “Next-year EPS rose to $15.02 from $14.87, with forecast EPS growth of 13.53%.”

Counter: The 90-day increase is only approximately 1.0%, while the latest 30-day revision breadth is 3 downward versus 1 upward. The 13.53% growth rate is a forecast rather than filed growth, and the current-quarter estimate has already declined 0.23% from $3.450 to $3.442. The valuation still requires approximately 27.06x forward earnings despite only 4.2% mean-target upside.

Bull said: “Operating margin of 66.13%, net margin of 50.78%, FCF of $20.404 billion, and an 8.5% share-count reduction provide high-conviction fundamental support.”

Counter: These figures are supportive but incomplete. Cash conversion, accruals, debt/EBITDA, and interest coverage are all N/A, while the current ratio is only 0.985x. The 8.5% reduction in shares supports EPS mechanically, but without cash-conversion data it does not establish that capital returns are fully supported by recurring operating cash flow.

Bull said: “Four consecutive earnings beats—0.28%, 0.88%, 6.79%, and 2.76%—show reliable execution.”

Counter: The record is positive, but the two smallest beats were only 0.28% and 0.88%, providing limited evidence of a large forecast cushion. More importantly, current-quarter EPS has been cut by 0.23%, and recent next-year revision breadth is 1 up versus 3 down. Prior beats do not protect the stock from a forward estimate reset.

Bull said: “Trend measures are strong: price is above the $374.22 50-day SMA and $338.92 200-day SMA; MACD is 9.20 versus 5.61; HMM bull probability is 0.88.”

Counter: These measures confirm an existing uptrend but do not establish attractive entry timing. RSI is 75.60, price is 19.9% above its 200-day average, and the quant engine’s reversal signals are deeply negative, including stochastic RSI −100 and RSI reversion −97. The Hurst exponent of 0.37 classifies the process as mean-reverting, directly challenging the assumption that strong momentum will persist.

Bull said: “Buying near $396.06 improves reward/risk, with a nominal 9.1:1 ratio to the $420 target.”

Counter: That ratio uses a very tight $2.63 stop distance despite a daily ATR of $6.75. Using the report’s more realistic 2x ATR risk allowance of $13.50, the reward/risk is only 1.77:1. At the current price of $406.57, the stated target is only 3.3% higher, while the $393.43 stop is 3.2% lower—just 1.03:1 before slippage or gap risk.

---

## RED FLAGS FROM ANALYST REPORTS

- Forward P/E is 27.06x and trailing P/E is 34.60x, with only 4.2% mean-target upside.
- Analyst target dispersion is 34.2%, with a range of $330 to $475.
- Current-quarter EPS estimate declined from $3.450 to $3.442, approximately 0.23%.
- Recent next-year revision breadth is 1 upward versus 3 downward.
- Current ratio is 0.985x, below 1.0x.
- Cash conversion, accruals, net debt/EBITDA, and interest coverage are unassessed.
- RSI is 75.60, while price is near the upper Bollinger Band: $406.57 versus $411.30.
- Quantitative reversal signals are strongly negative: RSI reversion −97, stochastic RSI −100, Bollinger position −86, and cointegration spread −96.
- Quant composite is only +18.0/100, with conviction of 1.9/10, despite a bullish HMM probability of 0.88.
- Insider activity shows 0 purchases and 2 sales totaling $2.8 million.
- Monte Carlo 21-day downside tail is −9.34%, versus expected return of only +1.11%.

## BEAR THESIS CONFIRMATION SIGNAL

The bear thesis accelerates if V closes below $393.43, the 10-day EMA and tactical momentum-warning level. A close below $374.22, the 50-day SMA, would confirm intermediate-trend deterioration and expose the $338.92 200-day SMA, implying approximately 16.6% downside from $406.57.

Fundamentally, confirmation would be next-year EPS consensus falling below $14.87, reversing the entire 90-day improvement, or a reported OCF/net-income ratio below 1.0x once the missing cash-conversion data become available.

## OVERALL BEAR CONVICTION: MEDIUM (6/10)

The strongest bear arguments are the combination of 27.06x forward P/E, only 4.2% mean-target upside, RSI 75.60, strongly negative mean-reversion signals, and a Monte Carlo fifth-percentile outcome of −9.34%. The valuation and technical risks can plausibly produce a 10–20% correction without requiring a collapse in the underlying business.

Conviction is not HIGH because the market regime remains bullish: SPY is 6.4% above its 200-day average, V is 19.9% above its own 200-day average, the HMM bull probability is 0.88, and the company has reported four consecutive earnings beats. Peer valuation, debt coverage, cash conversion, and filed growth data are also unavailable. The appropriate committee stance is therefore a medium-conviction bearish risk/reward view, strongest against chasing V above $406 rather than as proof of imminent fundamental impairment.

Want a fresh check?

A new AI check reads today's prices, news and filings. Compact check: one per month free with an account, ready in a few minutes. Full check with every analyst and chart technicals: in a plan or €3.99 once, about 10 minutes.

Start a new AI checkCheck your own entry (free)

Kairon's record on V

2 past checks: 0 directional calls (0 right, 0 wrong), 1 × wait (afterwards +11.0 % on average). Measured by price since each check, no costs. How we measure. Every 'not now' answer.

Oct 21, 2026: Long at $406.57, −1.2 % sinceflat
Jul 5, 2026: Wait at $362.13, anyone who bought anyway: +11.0 %wait

Insider and Congress filings

Loading…

Official SEC Form 4 and House PTR filings. Returns run from the first close after a filing became public. A filing is a fact, not a recommendation.

Full report (technical terms)

Key levels

Support$396.06
Resistance$411.30
Horizon3–6 months; evidence insufficient for a high-conviction long-term allocation
Quant score18/100

Executive summary

V retains a bullish directional bias, but the allocation assessment is NO_TRADE: the trader explicitly passed and proposed reward/risk is only 1.02:1. Over the next 1–4 weeks, overextension, conflicting quantitative signals and an unverified event calendar outweigh the modest upside available from the supplied entry. No new allocation is justified.

Investment thesis

The supplied snapshot shows V at $406.57 above its rising 50-day SMA ($374.22) and 200-day SMA ($338.92), with supportive volume and a BULL benchmark regime. These support a bullish bias rather than a short thesis, but do not override the trader's mandatory PASS. Reward of $13.43 versus risk of $13.14 gives 1.02:1, failing both the 2.5:1 short-term and 3:1 long-term requirements. The research manager report is empty, so a research-manager conviction cannot be extracted; the final 4/10 is an independent synthesis, not an attributed research score. The neutral analyst's provisional 68% win assumption produces approximately +1.21% simple EV, above the user's +1% floor, but is unvalidated; its alternative scenario-weighted EV of approximately -1.47% is likewise assumption-dependent. Neither establishes a robust edge. RSI 75.6, Hurst 0.37, and quant conviction 1.9/10 reinforce caution despite positive trend signals. The quant engine reports relative strength +77, but this does not resolve the missing comparable analyst RS assessment. Radar strength 0 warrants no conviction adjustment. Backtest lessons favor prioritizing reward/risk, corroborating fundamentals and technicals, avoiding countertrend shorts, and respecting volatility rather than tightening stops to manufacture attractive economics.

Valuation assessment

No P/E, EV/EBITDA, free-cash-flow yield or historical/peer multiple comparison is supplied, so fundamental valuation cannot be established. Technically, price is approximately 19.9% above its 200-day SMA with RSI 75.6; only 3.30% upside to the supplied $420 reference versus 3.23% downside makes entry economics unattractive despite the bullish trend.

Scenario analysis

Over 1–4 weeks, bullish continuation could encounter $411.30 and $420, with $423.80 a supplied consensus reference rather than a confirmed short-term outcome; sustained momentum would support this case. A base case is consolidation of an extended advance, without a defensible probability estimate. A bearish break through $396.06/$393.43 could expose the $374.22 50-day SMA; a severe shock could expose $338.92 over a longer or stressed horizon. The strong existing trend is counterevidence to an outright bearish thesis. Radar strength is 0 and supplies no event scenario IDs or directional catalyst; insider sales alone establish neither motive nor expected price effects.

Key risks

RSI 75.6 and strong reversion readings indicate pullback risk. A break of $396.06 and $393.43 could expose $374.22; $338.92 is a deeper stress reference, not a loss floor. Gaps can bypass the proposed risk reference. No verified earnings date or regulatory calendar is supplied; missing verification is not proof that a binary event exists. The conservative analyst's 5–9% stop requirement is not separately established in the user's mandate, but its wider-stop example demonstrates deteriorating economics. Supplied prices and indicators are treated as a dated analytical snapshot, not independently verified current quotations.

AI-generated. Created 2026-10-21 10:32 UTC automatically by Kairon AI (Cem Salomon Weidner, Vienna, Austria) at a price of $406.57. Valid for its time frame from that moment; it is not updated afterwards. Facts come from public sources (Yahoo Finance and others, partly delayed); the rating, levels and scenarios are opinions of the AI. General information, not investment advice and not a solicitation to buy or sell. Conflicts of interest, methodology and risks: disclosure. Every past call and its outcome: track record.

Open this analysis in the app

More checks

Learn the method

Kairon AI is an automated research and second-opinion tool, not a licensed financial advisor, broker, or investment manager. All assessments are AI-generated opinions based on public data and are informational only — not personal investment advice. Investing carries risk, including total loss of capital.

Impressum Privacy Terms Disclaimer